Capecitabine as Adjuvant Chemotherapy to Prevent Recurrence of Hepatocellular Carcinoma After Curative Resection: a Randomized Controlled Trial.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Capecitabine (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 21 Jul 2010 Biomarkers information updated
- 20 Jul 2010 Planned end date changed from 1 Nov 2012 to 1 Jul 2012 as reported by ClinicalTrials.gov.
- 06 Jul 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.